BVF Stock Overview
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Bausch Health Companies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$8.17 |
| 52 Week High | US$9.82 |
| 52 Week Low | US$5.14 |
| Beta | 0.86 |
| 1 Month Change | -1.95% |
| 3 Month Change | 7.00% |
| 1 Year Change | 21.61% |
| 3 Year Change | -65.10% |
| 5 Year Change | -60.66% |
| Change since IPO | -9.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| BVF | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -13.3% | -2.9% | -2.5% |
| 1Y | 21.6% | -31.3% | -0.4% |
Return vs Industry: BVF exceeded the German Pharmaceuticals industry which returned -29.6% over the past year.
Return vs Market: BVF exceeded the German Market which returned 1% over the past year.
Price Volatility
| BVF volatility | |
|---|---|
| BVF Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: BVF has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine BVF's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 20,270 | Tom Appio | www.bauschhealth.com |
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
Bausch Health Companies Inc. Fundamentals Summary
| BVF fundamental statistics | |
|---|---|
| Market cap | €3.01b |
| Earnings (TTM) | -€556.36m |
| Revenue (TTM) | €8.23b |
0.4x
P/S Ratio-5.4x
P/E RatioIs BVF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BVF income statement (TTM) | |
|---|---|
| Revenue | US$8.76b |
| Cost of Revenue | US$2.56b |
| Gross Profit | US$6.20b |
| Other Expenses | US$6.79b |
| Earnings | -US$592.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | -1.61 |
| Gross Margin | 70.78% |
| Net Profit Margin | -6.76% |
| Debt/Equity Ratio | -27,302.4% |
How did BVF perform over the long term?
See historical performance and comparison